1. Meaning

Commercial embryo auction refers to a hypothetical or actual commercial arrangement in which human embryos are offered to prospective recipients through bidding, competitive pricing, brokerage, or other market-based mechanisms.

It is fundamentally different from ordinary IVF services. An IVF clinic may charge for medical treatment, laboratory services, cryopreservation, implantation, and related healthcare, but an auction would treat the embryo itself, or its genetic characteristics, as the object of commercial competition.

In India, such an arrangement would face an exceptionally strong legal prohibition. The Assisted Reproductive Technology (Regulation) Act, 2021 (ART Act) expressly prohibits the sale of human embryos and related commercial trading. IndiaCode by eCourtsIndia

2. Indian Legal Position

The central provision is Section 29 of the ART Act, 2021.

It prohibits the sale, transfer or use of gametes, zygotes and embryos, or any part of them or information relating to them, directly or indirectly, to any party in or outside India, subject to the narrow exception concerning transfer of one's own gametes or embryos for personal use with National Board permission. IndiaCode by eCourtsIndia

Therefore, a conventional auction model such as:

“Embryo X — starting bid ₹5 lakh; genetically screened; highest bidder receives embryo”

would be fundamentally inconsistent with Section 29.

The prohibition is deliberately broad because it covers direct and indirect transactions.

3. Section 33 — Direct Prohibition on Selling Human Embryos

Section 33 is even more explicit.

It provides that a medical geneticist, gynaecologist, registered medical practitioner or any person must not:

• sell human embryos or gametes;
• operate an agency, racket or organisation for selling, purchasing or trading in embryos or gametes;
• import human embryos or gametes;
• exploit commissioning couples, women or donors;
• sell embryos or gametes for research; or
• use intermediaries to obtain gamete donors or purchase donors. Indian Kanoon

This has major implications for an auction.

Possible participants who could incur liability

The prohibition is not confined to IVF doctors. Depending on the facts, it could encompass:

• IVF clinics;
• ART banks;
• brokers;
• online auction platforms;
• commercial intermediaries;
• embryo purchasers;
• sellers;
• organisations facilitating the transaction.

Thus, describing an auction as a “platform fee,” “membership auction,” “genetic matching service,” or “premium embryo allocation” would not necessarily avoid the statute if the substance of the transaction amounts to prohibited trading.

4. Why an Embryo Auction Is Legally Different from IVF Fees

A crucial distinction is between payment for medical services and payment for the embryo itself.

Potentially lawful medical charges

A regulated ART clinic can charge for services such as:

• IVF procedures;
• laboratory processing;
• embryo culture;
• cryopreservation;
• storage;
• medical consultations;
• implantation procedures.

Problematic commercial transaction

By contrast:

“₹20 lakh for this particular embryo because of its genetic profile”

would look like consideration for the embryo itself rather than payment for medical services.

The legal issue therefore depends not merely upon the label attached to the transaction, but upon its substance and purpose.

5. Embryo Genetic Information Cannot Easily Be Used as an Auction Commodity

Section 29 is particularly significant because it does not merely prohibit the physical sale of embryos. It also refers to information related to gametes, zygotes and embryos. IndiaCode by eCourtsIndia

Consequently, a sophisticated commercial model could not necessarily escape regulation by saying:

“We are not selling the embryo; we are auctioning access based on its genetic information.”

For example, a platform advertising embryos according to:

• predicted physical characteristics;
• genetic disease risk;
• sex;
• intelligence-associated characteristics;
• athletic potential;
• ancestry;
• genetic compatibility;

could create additional legal and ethical problems, particularly where the information is being used as the basis for prohibited commercial dealing.

6. Embryo Storage and Ownership

Section 28 of the ART Act regulates the storage and handling of human gametes and embryos.

It requires prescribed standards concerning:

• security;
• recording;
• identification; and
• handling.

The Act also provides that donor gametes or embryos may be stored for a maximum period of ten years, after which they may perish or be donated to a registered research organisation with the required consent and in accordance with the prescribed procedure. IndiaCode by eCourtsIndia

This is important because an embryo cannot simply be treated like ordinary property sitting in a warehouse awaiting a future auction.

The statutory framework instead treats embryo storage as a regulated reproductive-medical activity.

7. Embryo Auction and Property Law

A difficult theoretical question is:

Is a human embryo “property”?

Ordinary property-law concepts cannot simply be applied to human embryos.

An embryo has biological characteristics fundamentally different from:

• shares;
• land;
• commodities;
• securities;
• livestock;
• ordinary personal property.

Consequently, a contract purporting to transfer an embryo through a commercial auction could face problems concerning:

1. statutory prohibition;
2. public policy;
3. informed consent;
4. bodily and reproductive autonomy;
5. dignity;
6. parentage;
7. future rights of the resulting child.

The ART Act resolves much of the issue legislatively by prohibiting commercial sale and trading.

8. Constitutional Dimension

Even though the ART Act imposes restrictions, constitutional principles remain important.

A. Article 21 — Reproductive autonomy

In Suchita Srivastava v. Chandigarh Administration, (2009) 9 SCC 1, the Supreme Court recognised reproductive choice as an aspect of personal liberty under Article 21. The Court emphasised the importance of consent and reproductive autonomy. Indian Kanoon

This principle has two sides.

First

Individuals have significant constitutional interests in deciding whether and how to reproduce.

Second

That autonomy does not automatically create a constitutional right to commercially purchase or sell another human embryo.

Therefore:

Reproductive autonomy ≠ unrestricted commercialisation of reproductive material.

9. K.S. Puttaswamy and Genetic/Reproductive Privacy

In Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1, the Supreme Court recognised privacy as a fundamental right under the Constitution.

The judgment linked privacy with concepts including:

• dignity;
• autonomy;
• bodily integrity;
• decisional freedom;
• personal choices.

It also relied upon reproductive-choice jurisprudence such as Suchita Srivastava. Indian Kanoon

An embryo-auction system would therefore create serious privacy questions concerning:

• genetic profiles;
• donor identities;
• prospective parents;
• reproductive histories;
• hereditary disease information;
• future child's genetic information.

A commercial database publicly ranking embryos by genetic characteristics could raise particularly serious privacy and dignity concerns.

10. Devika Biswas v. Union of India

In Devika Biswas v. Union of India, (2016) 10 SCC 726, the Supreme Court dealt with reproductive-health rights and stressed the State's responsibility to protect people from unsafe and unethical reproductive-health practices. The Court recognised reproductive health as connected with Article 21 and personal liberty. Indian Kanoon

Although the case concerned sterilisation rather than embryos, its broader principle is relevant:

Reproductive healthcare cannot be reduced to an unregulated commercial transaction where vulnerable persons can be exploited.

This supports strong regulatory supervision of any commercial embryo marketplace.

11. Baby Manji Yamada v. Union of India

Baby Manji Yamada v. Union of India, (2008) 13 SCC 518 is an important Indian reproductive-technology case.

The case arose from an international surrogacy arrangement and involved questions concerning the custody and status of a child born through surrogacy. The Supreme Court dealt with the case in the context of the absence, at that time, of a comprehensive statutory framework governing surrogacy. Indian Kanoon

The case is particularly useful for understanding why commercial reproductive arrangements can create complicated questions concerning:

• parentage;
• nationality;
• custody;
• contractual arrangements;
• exploitation;
• child welfare;
• cross-border reproductive services.

It does not, however, establish a right to commercially sell embryos.

Indeed, the subsequent statutory regime is much more restrictive.

12. Recent Supreme Court Development

A particularly relevant development is the Supreme Court's 2025 consideration of reproductive material and the transition into the post-ART statutory regime.

In a 2025 judgment concerning embryos created before the ART/surrogacy regulatory regime came into force, the Court considered whether rights associated with previously fertilised embryos were affected by the subsequent statutory regime. The Court emphasised the significance of the timing of fertilisation and the rights of intending parents under the earlier legal framework. Sci API

This demonstrates an important principle:

Transitional rights concerning an existing embryo are different from a general right to commercially trade embryos.

A court recognising certain reproductive interests of intending parents does not imply that embryos may subsequently be placed on a commercial auction market.

13. Frozen Embryo Donation

An important contemporary issue is the distinction between:

commercial sale,
donation, and
medical transfer.

Indian law currently imposes significant restrictions on the use or transfer of surplus frozen embryos.

Recent legal discussion concerning frozen-embryo donation has highlighted that the ART Act does not simply establish an American-style “embryo adoption” market. The statutory provisions concerning embryo use, storage and transfer must be read together. The Indian Express

Thus:

Donation is not equivalent to auction.

Even if a future policy permitted some form of altruistic embryo donation, that would not logically authorise commercial bidding.

14. International Comparison — United Kingdom

The UK's Human Fertilisation and Embryology Act 1990 adopts a licensing model.

The Act regulates the creation, keeping and use of embryos and generally requires licensed authority for those activities. It also regulates procurement and distribution of embryos intended for human application. Legislation.gov.uk

The UK approach therefore demonstrates another regulatory model:

Human embryos are subject to specialised reproductive regulation rather than ordinary market-property regulation.

India goes further in expressly prohibiting the sale/trading of human embryos.

15. Regulatory Model for Preventing Embryo Auctions

If a legislature wanted to address the phenomenon specifically, an effective regulatory framework would contain at least the following components:

A. Absolute prohibition on commercial bidding

No person should be permitted to auction an embryo for monetary or other valuable consideration.

B. Licensing

Only authorised ART clinics and banks should be permitted to handle embryos.

C. Traceability

Every embryo should have a secure identification and recordkeeping system.

D. Consent

Creation, storage, transfer and permitted disposition should require properly documented consent.

E. Genetic-data protection

Genetic information should not become a publicly tradable commodity.

F. Anti-broker provisions

Third-party intermediaries should be prohibited from creating embryo markets.

G. Cross-border controls

International transfer should be subject to statutory restrictions and regulatory permission.

H. Criminal sanctions

Commercial sellers, purchasers, brokers and facilitating organisations should face appropriate statutory penalties.

16. Hypothetical Example

Suppose an online company creates the following marketplace:

Embryo A: ₹2 lakh
Predicted low risk of certain inherited diseases

Embryo B: ₹10 lakh
Donor genetic profile marketed as medically desirable

Embryo C: ₹25 lakh
Advertised as possessing desirable genetic characteristics

Users bid against each other.

Indian legal analysis

This arrangement would likely involve multiple prohibited activities:

1. sale of embryos — Section 33;
2. commercial trading — Section 33;
3. potentially prohibited transfer/use — Section 29;
4. commercial exploitation;
5. potentially unlawful handling of genetic information;
6. regulatory violations by the ART clinic or bank;
7. possible additional offences depending on the characteristics of the transaction.

Calling it a “donation auction” would not automatically cure the problem.

17. Constitutional Test

A proposed law regulating embryo auctions would generally have to be examined against:

Article 14

The classification between legitimate ART services and prohibited embryo commerce must have a rational basis.

Article 19

Commercial speech or business interests cannot automatically override statutory restrictions designed to protect health, dignity and reproductive ethics.

Article 21

The State must balance:

• reproductive autonomy;
• privacy;
• bodily integrity;
• dignity;
• interests of prospective parents;
• interests of donors;
• welfare of children;
• prevention of exploitation.

Puttaswamy and Suchita Srivastava provide important constitutional foundations for this analysis. Indian Kanoon

18. Major Legal Principles

19. Conclusion

Commercial Embryo Auction Regulation in India is best understood as a prohibition-oriented legal regime rather than a licensing regime for embryo markets.

The central statutory provisions are Sections 28, 29 and 33 of the Assisted Reproductive Technology (Regulation) Act, 2021. Section 29 restricts the sale, transfer or use of gametes, zygotes and embryos, while Section 33 expressly prohibits selling, purchasing or trading in human embryos and gametes. IndiaCode by eCourtsIndia

The constitutional jurisprudence adds another layer: Suchita Srivastava protects reproductive choice; Puttaswamy protects privacy and decisional autonomy; Devika Biswas emphasises protection against unethical reproductive-health practices; and Baby Manji Yamada illustrates the complex legal consequences of commercial reproductive arrangements. Indian Kanoon

Accordingly, the strongest legal proposition is:

An embryo may be the subject of regulated medical and reproductive processes, but under the present Indian ART framework it cannot lawfully be converted into an auction commodity.

Note: This is an academic legal analysis, not legal advice. The National ART & Surrogacy Portal currently lists the ART Act, ART Rules and subsequent amendments, including 2026 amendment notifications, so the latest rules should be checked for litigation or professional use. artsurrogacy.gov.in